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INTRODUCTION 
 
 
 
 
 The WHO in 1984 considered that 3% of total population was 
infested with Filaria i.e. (90 million people) with atleast 45 million 
clinically affected by it. (1) 
 
 
The disease as it progresses tends to undermine the ability of an 
individual to work, to contribute their family, in addition to his/her 
suffering which are both physical and psychological. Pain due to 
recurrent infection, impaired mobility, poor hygiene, loss of self esteem, 
depression and adjustment disorders to name a few. (2) 
 
 
Though, prevention is ideal, considering the magnitude of the 
problem, any effort or management strategy that would decrease the 
morbidity by retarding or arresting the progression of disease will be of 
immense value to the patients by helping him / her to be less dependent 
and more productive to the community itself.  
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OBJECTIVE OF THE STUDY 
 
 
 
 
 
To analyse and compare the outcome of Pump therapy and 
Nodovenous Shunt on Early Filarial Lymphedema. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
REVIEW OF LITERATURE 
 
 
BASIC SCIENCE: 
 
ANATOMY:- 
 
 
The lymphatic system consists of 
 
- Lymph capillaries where lymph is formed and collected 
- Lymph vessels which carry the lymph to the regional lymph nodes  
- The larger collecting channels, emptying the lymph into the venous 
system in the neck via the thoracic duct and the right lymphatic 
trunk. (3) 
 
 
Micro anatomy:    
Salient Features:- 
 
 
 Lymph capillaries consists of single layer of epithelial cells. They 
do not have any basement membrane and are surrounded by the loosely 
adherent collagen tissue. 
 
 The functional unit is lymphangion which is segmentally 
contractile. 
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 The intercellular junction of the capillary wall has minute clefts 
with overlapping of the cells to act as flap valves. A small proportion of 
these can open widely to accommodate fluid as required, being held apart 
by collagen microfibrils which open up very widely. 
 
 Essentially the structure is the same as blood capillaries but here 
the holes are more profuse – from 1% to 6% of the capillary surface area. 
 
 The lymph capillaries can distend two to three times of their size 
and also constrict to make their lumen invisible. 
 
 The lymph vessels have unidirectional valves which allow lymph 
to flow in a centripetal direction. 
 
 
 These valves are located about a centimeter apart to make the 
lymph vessels appear like a string of pearls. 
 
 The lymphatics of the skin are distributed with a proportion 
equalling that of the blood capillary system. (4) 
 
 It is delineated as superficial and deep systems that ramify 
throughout the body contiguous with the venous system but separate from 
it. (5) 
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In the subcutaneous tissue, the valved collecting channels run 
obliquely or vertically within connective tissue strands linked by 
horizontal arcades.  
 
 These empty into the main lymphatic trunk close to the deep fascia. 
 
 Muscles in the body have no lymphatic supply, but the lymph 
trunks have been found next to the perimysium internum i.e., around the 
blood vessels. 
 
 
 
PATHOPHYSIOLOGY: 
 
 Lymphedema describes a clinical condition in which there is 
accumulation of interstitial fluid. 
 
 
 This pathologic accumulation may be due to congenital mal 
development of lymphatic system (primary) or an acquired condition 
(secondary). 
 
  
5 
 In lymphedema the delineation between superficial and deep 
system becomes indistinct with onset of lymphatic obstruction resulting 
in communication in superficial and deep systems and between lymph 
and venous channels. (6) 
 
 
 The main function of lymphatic system is to clear proteins and 
lipids from interstitial space to the vasculature by use of differential 
pressure. 
 
 
 The intra lymphatic pressure is low. Muscle contraction and 
differential of abdominal and intrathoracic pressure occurring with 
respiratory effort propel lymph. Fat and protein diffuse into the numerous 
intercellular gaps into lymphatic capillaries. Thus it is able to clear nearly 
half of the circulating albumin from interstitium every day. (7) 
 
 
When there is a disruption to the flow due to whatever the cause 
may be – i.e., primary or secondary – lymphatic load exceeds capacity. 
Intralymphatic pressure builds which leads to flow stagnation and 
valvular incompetence. These factors in combination leads to dermal 
back flow resulting in accumulation of protein rich fluid in extra cellular 
space. (8) 
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This fluid which is rich in macro molecular protein and hyaluronan 
accounting for increased colloid osmotic pressure resulting in influx of 
water and increased interstitial hydraulic pressure. (9) 
 
 Also there is increase of fibroblasts, monocytes, adipocytes and 
keratinocytes in tissues leading to fibrovascular proliferation which 
contribute to the brawny non-pitting edema. (9,10) 
 
 Degeneration and thickening of elastic fibers of basement 
membrane of lymphatic channels leading to obliteration of the channels 
due to proliferation of ground substance, inflammatory cells and 
fibroblasts. (11,12) 
 
CLASSIFICATION: 
 
 It is based upon distinction between primary and secondary causes 
of the disease. 
 
Primary lymphatic obstruction may be due to, 
Lymphatic hypoplasia 
Functional insufficiency  or 
Absence of lymphatic valves   (3) 
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Based on the time of manifestation, it has been classified as,  
 
 Lymphedema Congenita – within first two years of life  
              (Milroy's disease) 
 Lymphedema precox (early lymphedema or Meige disease  
     diagnosed during puberty can appear  
               as late as the third decade) 
 
 Lymphedema tarda – presents after 35 years of age 
 
 
Another classification based on the morphologic characteristic of 
lymphatics as seen in lymphangiography. 
 
 
 Aplastic lymphedema – shows normal dermal plexus with total 
           absence of subcutaneous lymphatics. 
   Hypoplastic lymphedema:   
Obstructive 
             Non-obstructive 
- Distal hypoplasia of lymphatics with 
bilateral peripheral edema of lower 
extremities.  
 
8 
    Obstructive: -       decrease in number of proximal lymphatics 
      Non-obstructive:- adequate number but inadequate caliber 
                                             of vessels. 
 
Lymphatic hyperplasia with mega lymphatics. – shows an increase 
in both size and number. Presents with 
unilateral edema of entire lower extremities. 
(13) 
 
 
Secondary lymphatic edema 
 
 The causes include surgical, traumatic, infections, inflammatory or 
neoplastic that results in compromise of lymphatic pathways. 
 
 
 Among the secondary causes, Filariasis is the leading one affecting 
more than 90 million people. In the western hemisphere, secondary 
lymphedema is a sequale to surgery or radio therapy. (14) 
 
DIAGNOSIS: 
 Diagnosis of lymphedema is by and large clinical based on the 
history and physical findings. For the same reason, it is observer 
dependant.  
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History: 
 
 Symptoms such as swelling, its duration, any painful episodes, 
regional adenitis or ascertained. As far as the signs, the classical ones are 
peau de orange, Stemmer Sign – inability to tent the skin over the toes – 
and the blunted appearance of the digits of the involved extremities. (15) 
 
 As far the objective assessment goes circumferential limb 
measurement has been most commonly used with a difference of 2 cms 
from the opposite limb considered significant. Other tests used are 
Volume displacement and Serial Photography. (16) 
 
DIFFERENTIAL DIAGNOSIS: 
 
Edema due to pregnancy  
 Chronic Venous Insufficiency 
 Myxedema in hypothyroidism 
 Thyrotoxicosis,  
Lipedema – abnormal accumulation of subcutaneous fat between  
                    pelvis and ankle.   Mostly affecting  hips  and  thighs, 
                    usually sparing the feet. 
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DIAGNOSTIC STUDIES: 
 
 Contrast Lymphangiography 
 Indirect Lymphangiography 
Isotopic Lymphoscintigraphy  -   Widely  practiced. Used as a 
corner stone in   the  diagnosis,  classification   and  
evaluation of lymphedema. Tc 99m labeled antimony 
sulfide colloid, Rhenium sulphate or Human  serum 
albumin nano colloid is injected into the dermis in the 
inter digital space of the affected   limb. A gamma 
camera is used to follow transport of Macro molecule 
providing both static anatomic information and 
dynamic assessment of lymph flow.  Former being 
useful for evaluation of moderate to severe 
lymphedema and the latter useful for mild forms of 
lymphedema. (16) 
  
Other Modalities:- 
  MRI 
  CT – SCAN 
  ULTRASONOGRAPHY 
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 In MRI / CT-SCAN, Chronic lymphedema of epifascial 
compartment exhibits a characteristic honey comb appearance 
differentiating it from venous edema which affects both epifascial and 
subfascial compartments.  
 
 
Ultra-Sonography is a valuable non invasive method to quantify 
the volume of edematous lower extremities. (16) 
 
LYMPHATIC FILARIASIS – AN OVERVIEW  
 
 It covers infection with three closely related nematode worms. 
Wuchereria bancrofti, Brugia malayi and Brugia timori.  
 
 
All three are transmitted to man by bites of infectious mosquitoes. 
(Viz. Culex, Mansonia, Anopheles species) 
 
 
All three parasites have similar life cycle with man being the 
definitive host and the vector – mosquito – the intermediate host. (17) 
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Life Cycle: 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Clinical Manifestation: 
 
 It varies over a spectrum.   
 
 
 
 
 
 
 
 
 
 
 
 
(18) 
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Human 
Vector 
Human 
infected 
when vector 
bites 
Larva 
migrates to 
destination 
and develop 
into adults 
Male – 2.5 to 4 cms 
Female- 8.to 10 cms 
Adult worms 
Females produce 
Microfilaria 
Microfilaria to 
blood or skin 
Mf-290 µm
Microfilaria 
ingested by vector 
Development in 
the vector 
Infected larvae 
in the vector 
after 
Exsheathing 
(10 – 14 days) 
(8 – 16 months) 
None 
Asymptomatic 
Microfilaremia 
Filarial fever Chronic 
lymphatic 
pathology 
- Lymphedema  
   of limbs  
- Chyluria  
- Hydrocoele 
- Elephantiasis 
Tropical 
pulmonary 
eosnophilia 
 
When it manifests, it can be acute or chronic. 
 
 
Acute - Fever, lymphangitis, lymphadenitis, reversible 
lymphedema of various parts of the body, 
epididymoorchitis in male. 
 
 
Chronic -  This is due to fibrosis and obstruction of lymphatic 
vessels leading to permanent structural changes seen 
as, Lymphedema of different grades Chyluria,       
Hydrocele  and Elephantiasis in its worst form. 
 
 
Lymphedema in filariasis: 
 
 The adult worms localise in the lymphatics and cause blockage of 
the lymphatic trunks to result in lymphedema. Repeated lymphangitis 
related to release of microfilaria is however common. Macrophage action 
as well as the release of complement and other inflammatory proteins 
results in blockage of a wider group of lymphatics. (19) 
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 In endemic areas, massive infections as well as reinfection by 
streptococcal infection are responsible for the lymphedema.  
 
Lymphangitis is due to,  
 
- Mechanical irritation 
- Liberation of toxic fluid by the female worm during 
parturition. 
- Paralysis of Lymphatic peristalisis by the toxins  
- Absorption of toxic product or allergen by the disintegration 
of the adult worm. 
- Secondary streptococcal infection 
 
The essential feature being the blockage of lymphatics over a 
distance of few centimeters at a certain level or even all through the limb.  
 
 Elephantiasis – the extreme end of the spectrum with 
dermatosclerosis and pappillomatous changes in the skin is due to, 
 
- Repeated infection of multiple lymph channels 
- Endo lymphangitis of the proximal portion obstructing 
lymph flow. 
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- Dilatation of the distal part of the lymphatics and lymph 
stasis leading to fibrotic changes. 
 
- Infection  
 
- Inability to establish adequate collaterals through 
hypertrophied tissues. 
 
 
Diagnosis:- 
 
 
  Usually the diagnosis is made from the following 
 
- History 
 
- Clinical features  
 
- Lymphangiogrphy 
 
- Lymphoscintigraphy 
 
- CT Scan 
 
- Study of lymph fluid 
 
- Night blood smear for microfilariae  by Millipore technique 
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- Tests to rule out TB, LGV 
 
- Cytoimmunochemistry – Detection of filarial antigen and antibody 
   Serum immunoglobulins 
 
- Urine examination and microscopy 
 
- Radio-iodine human serum albumin (rihsa) uptake studies. (20) 
 
 
History:  
 
 
 Recurrent attacks of fever with chills accompanied by adenitis. 
Swollen limbs – reversible or irreversible,  
Genital swelling    
Place of dwelling (if within endemic area)  
 
 
Clinical Features:- 
 
 
 
 As the patients present mostly if not invariably with edematous 
limbs, this becomes the single most important finding in filariasis.  
 
 In view of assessing the severity of the disease, a grading system is 
employed to grade the edematous limbs.  
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Grading:- 
 
 
Grade I    - Mostly pitting edema.  Clinically no or some fibrosis.                     
Spontaneously reversible on elevation of limb. 
 
Grade II   - Mostly Non-pitting edema. Moderate to severe fibrosis. Not  
spontaneously reversible on elevation of the limb. 
 
 
Grade III  - Increase in circumference of limb more than 5 cm at one or 
more levels when compared to normal limb irrespective of 
increase in size. 
 
Grade IV  - Limbs with pappillomatous and a warty projection in the 
edematous limbs irrespective of size of the limb.  (21) 
 
Specific test for detection of Microfilariae: 
 
 
Detection of microfilariae in blood: 
 
 
 Capillary finger-prick or venous blood is used for thick blood 
films.  Venous blood also can be concentrated or passed through a 
Nucleopore filter before being examined microscopically. The species of 
infection then can be determined by the microscopic appearance. 
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 Microfilaria may be periodic in appearance in the peripheral 
circulation, and the blood should be examined at different intervals over a 
24-hour period to achieve the best chances of detection. 
 
 
 Provocation of nocturnally periodic microfilariae may be achieved 
with a daytime dose of DEC at 1-2 mg/kg. 
 
 
 Microfilariae also may be observed in chylous urine and hydrocele 
fluid. 
 
 Microfilariae may be absent in patients with Adeno Lymphangitis 
or late chronic lymphatic disease. 
 
 
Detection of filarial antigen:- 
 
 The presence of circulating filarial antigen in the peripheral blood, 
with or without microfilariae, now is considered diagnostic of filarial 
infection and is used to monitor the effectiveness of therapy.  Commercial 
kits are available to test venous blood. 
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Complete blood cell count: 
 
 Eosinophilia is marked in all forms of patients with filarial 
infection. 
 
 
Serum immunoglobulins: 
 
 Elevated serum lgE and lgG4 may be observed in patients with 
active filarial disease. 
 
Histologic Findings: 
 
 Affected lymph nodes fibrose. 
 
 Lymphatics stenose and get obstructed with the creation of 
collateral channels. 
 
 The skin of individuals with elephantiasis is affected with 
hyperkeratosis, acanthosis, lymph and fatty tissue, loss of elastin fibers, 
and fibrosis. 
 
Lymphangiography:- 
 
 A radio-opaque dye lotrolan has been used to delineate lymphatics 
radiologically after subcutaneous injection. 
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 Present day techniques use ultra-fluid Lipiodol, a fatty based 
substance as contrast injected via a special slow injector pump.  (18) 
 
 In secondary lymphoedema, the changes are of dilatation leading 
on to dermal back flow, varicosity, tortuosity and obliquity. 
 
 The initial changes in lymphangiography are of secondary 
lymphoedema but at a later stage, they may get fibrosed and decrease in 
number. 
 
 Grades I and II shows extensive proliferation, varicosities and 
collaterals which decrease with severity. 
 
 
 In later grades, the lymph vessels decrease in number but still 
exhibit dermal back flow. 
 
 Thus an elephantiatic limb (gr. IV) shows very few lymph 
channels. 
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THE INDIAN SCENARIO: 
The Problem:- 
  
• 429 million people exposed to risk of infection 
• 31.3 million are microfilaria carriers 
• 7.8 million lymphoedema / elephantiasis cases 
• 12.9 million hydrocele cases 
 
• India alone accounts for 42.8% of global problem due to 
W.bancrofti and 20.2% due to B.malayi. 
 
 
The distribution 
 
• The traditional endemic foci are situated around river basins and 
eastern and western coastal areas. 
 
• Of the 25 States / Union territories surveyed in India, 22 are 
endemic. 
 
• Nine States (Andhra Pradesh, Bihar, Gujarat, Kerala, 
Maharashtra, Orissa, Tamil Nadu, Uttar Pradesh and West 
Bengal) contribute around 95% of overall burden. 
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The burden: 
 
• Annual economic loss to India due to filariasis is to the tune of 
US $ 1.5 billions. 
• Loss of income to individuals and families. 
• Loss of productivity 
• Functional impairment and restricted mobility 
• social stigma and isolation, psychological stress and family 
discord 
• Poor marriage prospects and employment opportunities 
• Occupational displacement 
• sexual disability 
• Poor quality of life   (22) 
 
 
National Filaria Control Programme: (NFCP) 
 
NFCP has been in operation since 1955. 
NFCP is being implemented through 206 filaria control units. 199 
filaria clinics and 27 survey units primarily in endemic urban towns.  
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 Revised Filaria Control Strategy: 
 
 
 WHO recommendation of single dose mass drug administration 
with DEC / DEC + Albendazole.  
 
 
 Goal is to eliminate lymphatic filariasis by 2015. 
 
 
 Broadly, control programme includes Vector control through anti 
larval operations, source reduction, detection and treatment of 
microfilaria carriers and morbidity management.  (17,22) 
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MANAGEMENT OF LYMPHEDEMA 
 
Medical Management: 
 
 Limb elevation with massage and exercises.  
 
Compression therapy – Uniform pneumatic compression    
 
Sequential compression by hydrostatic pressure  
 
Sequential pneumatic compression 
 
 Complex physical therapy 
 
 Pharmacotherapy 
 
Surgical Management: 
 
Physiologic techniques 
 
  Lymphangioplasty 
 
Bridging techniques 
 
  Lymphatic anastamoses 
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- Lymphatic – Lymphatic 
- Lymphatic venous  
- Lymphatic Venous Lymphatic 
- Lymph node Venous anastomosis 
- Microlymphatic – Venous anastomosis 
(MLVA) 
 
Excisional Techniques: 
- Charles' 
- Kondoleon 
- Sistrunk  
- Homans' 
 
Suction Assisted Lipectomy 
 
Medical Management:- 
 
 The basic principle involved is avoidance of secondary infection 
and application of compression to maintain or improve limb volume.  
 
 
 A number of modalities and protocols have been devised and 
practiced.  
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- Limb elevation along with massage and exercises with or without 
compression garments. 
 
- Compression therapy which can be uniform pneumatic 
compression or sequential compression by the hydrostatic pressure.  
 
- Complex physical therapy also known as Complex Decongestive 
Therapy (CDT). 
 
 
 This is carried out in stages and in two phases.  
 
  Ist Phase:      As an in-patient 
  IInd Phase:   Self management 
 
The steps include:  
 
Hygienic measures to avoid fungal and streptococcal infection in 
particular. 
 
Manual Lymph Drainage (MLD) 
 
Here, special massage technique is commenced on contralateral 
quadrant of the trunk which is free of lymphostasis to increase 
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lymphokinetic activity in normal tissues. Ultimately, facilitating drainage 
across lymphatic water shed.  (23) 
 
Manual lymphatic mapping – is to locate the direction or route of 
drainage of lymph for specific areas.  
 
Concomitant application of elastic bandage which, not only counter 
balances the elastic insufficiency but also increase tissue pressure.  
 
Remedial exercises performed with bandages worn which exert 
lymphokinetic effect.  
 
At conclusion, i.e. 4 weeks, elastic stocking support is prescribed 
with the main objective of prevention of re-accumulation of fluid. (24-27) 
 
Pump Therapy:- 
 
 The use of pumps has been in vogue in the past 50 years. The 
methods employed have been either uniform or sequential compression. 
A proposed theory for the action of pumps is based on the fact that, 
pressure generates heat. And based on the universal gas equation PV/T = 
Constant. i.e. at Constant Volume (V) rise in pressure (P) results in rise in 
temperature (T) which is known to bring about reduction. A word of 
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caution has also been sounded that compression should not be in rapid 
increments of pressure but in smaller increments for longer duration, 
especially while using sequential pump therapy. (28,29) 
 
 Some of the studies show convincing results in non-malignant 
early lymphedema for Pump therapy. One criticism against Pump therapy 
has been the cost factor. To circumvent this, efforts have been made to 
design cost effective indigenous pumps that can work effectively and 
easily, thus making it available for more number of patients.  
 
 
Heat and Bandage Therapy:- 
 
 
 An electro controlled heating chamber with the temperature to 120o 
C elevates the temperature of extremity by 6o – 7o C. Upto 1 hour once a 
day for 20 days. 3 to 5 cycles are given. (27) 
 
 
Pharmaco Therapy: 
 
 
 Drugs that have been employed are benzopyrene (Coumarin), 
flavinoids, antibiotics. DEC (Diethyl Carbamazine) forms an integral part 
of the treatment of filarial lymphedema. (27) 
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DEC is known to alter the membrane of microfilaria so that they 
are readily phagocytosed by tissue fixed monocytes but not circulating 
phagocytes. Prolonged  treatment may be wormicidal.  
 
 
 Other drugs used are albendazole and ivermectin. 
 
 
Surgical Techniques: 
 
 Physiological techniques which favor or enhance lymph drainage.  
 
 
Lymphangioplasty: 
 
 Placement of silk sutures into subcutaneous tissues of 
lymphedematous extremities would act by capillary force to promote 
lymphatic flow.  
 
Bridging Techniques: 
 
 Disruption of underlying fascial barrier to establish communication 
between deep and superficial systems of lymph drainage. Kondoleon was 
the proponent.  
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 As an extension of this method, interposition of normal tissue into 
lymphedematous area to enhance drainage of the obstructed systems.  
 
 Thompson used a buried dermal flap. 
 
 
 Enteromesentric bridge co-apted to inguinal lymph node to bye-
pass obstructed pelvic nodes. 
 
 Omental transfer, musculocutaneous and fasciocutaneous flaps 
attached to lymphedematous sites have been tried. (30) 
 
 
Lymphatic anastamoses:- 
  
 Different Anastamoses are described and practiced in an attempt to 
relieve obstructed lymphedema. 
 
 Lymphatic – Lymphatic 
Lymphatic venous  
Lymphatic Venous Lymphatic 
 
Lymph node – Venous (Nodovenous Shunt – Nieulubowicz, Olszweski). 
(31) 
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 Co-apting of a sectioned lymph node to an adjacent vein based on 
the fact that high pressure lymphatics would drive drainage of lymphs 
into venous system.  This was popularized and put into practice in our 
country by Prof.S.Jamal. 
 
 
 Microlymphatic venous end to end anastomosis by O' Brien 
(MLVA) between lymphatic vessels and veins has shown good 
results.(32) 
 
 Interposition of vein grafts between lymphatic channels both 
proximal and distal to the site of obstruction. (33) 
 
 These techniques have been used in isolation or in combination 
with excisional techniques.  
 
Excisional Techniques: 
 
 Charles' procedure – Involves radical excision of all involved 
lymphedematous tissue including skin, subcutaneous tissue and fascia. 
The resultant wound covered with split or full thickness skin grafts.   
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 Kondoleon suggested staged excision of subcutaneous tissue.  This 
was later modified/refined by Sistrunk and popularized by Miller and 
Homans'. This procedure has been the main stay of excisional techniques.  
 
 
All these patients require elastic support in the form of stockings to 
maintain the post operative results. (34-37) 
 
Suction Assisted Lipectomy:- 
 
 This is usually combined with another procedure such as 
lymphovenous anastamosis or surgical excision. (38) 
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MATERIALS AND METHODS 
 
 
 
Background of the Study: 
 
 
 The study was carried out at the Department of Plastic 
Reconstructive Surgery, Thanjavur Medical College Hospital (TMCH) 
  
 
 Since Thanjavur and the surrounding areas are endemic zone for 
Filariasis, the Department runs a special clinic for filarial patients.  
 
CENSUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2004 2005 2006 2007 
Beds 
Allotted 
10 10 10 10 
Total OP 
Attendance 
5458 4863 669 5931 
New Cases 513 460 196 259 
Old Cases 4945 256 473 5672 
Admissions 93 57 68 59 
Operations 74 88 66 55 
Major 65 79 52 45 
Minor 9 9 14 10 
34 
 
Existing Protocol in treating Filarial Lymphedema patients. 
 
Patients are seen in the filarial Out-patient Clinics on Mondays. 
New cases are entered serially in a separate Registry. They are started on 
Penidure prophylaxis.  
 
 Apart from routine screening, Grading of the limbs is done as per 
recommendations.  
 
 Irrespective of the Grade, they are advised regarding hygiene, 
avoidance of infection, to practice Limb elevation as much as possible.  
After 2-3 doses of Penicillin prophylaxis-injection Benzathine penicillin – 
12 lacs units IM after test dose + DEC – 100 mg BD for 3 days – (When 
patients are found allergic to Penicillin, they are treated with Doxycycline 
100mg BD for 3 days) Grade I & II patients are subjected to Nodo-
venous shunt. 
 
 Grade III & IV – Nodo-venous shunt followed by reduction 
surgery in 1 week to 10 days time. Post-operatively, all of them are 
advised to wear compression stockings / elastocrepe bandage and advised 
to report for continuing Penidure prophylaxis, during which they are 
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evaluated for any recurrent infection, increase in edema and other 
complications.  
 
 
 Recording of limb measurements is usually carried out by taking 
circumferential measurements at standard sites of both foot and leg. 
Sometimes, volumetric measurement is carried out using a specially 
designed chamber for displacing water. 
 
 
 
Duration of the study:   
 
Over a period of 2 years – February 2007 to February 2009  
 
Selection of patients:- 
 
Patients were selected as they approached the Filarial Out-patient 
clinic for Penidure (Benzathine penicillin) prophylaxis.  A broad outline 
of the treatment, whether be it, Pump therapy or Nodovenous shunt 
therapy, was explained to them and were included in the study after 
obtaining an informed consent.  After this they were admitted as 'In-
patients'. 
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GRADE I LYMPHEDEMA 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GRADE II LYMPHEDEMA 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LEG LEVEL: 10, 20, 30 CMS 
MEASUREMENTS 
FOOT LEVEL: 12 CMS 
Inclusion criteria:-  
 
- Patients from both sexes were involved 
 
- All were adult patients 
 
- Patients belonging to Grade I and II of Filarial Lymphedema 
classification alone were included. 
 
- Allotment to a specific modality Nodovenous shunt / Pump therapy 
was done on alternate basis. 
 
- Patients with known co-morbid factors such as Diabetes Mellitus, 
Hypertension, Ischemic heart disease, Immuno suppressive disorders 
were excluded from the study. 
 
 
Evaluation: 
 
 On admission, circumferential measurement at standard sites both 
in the foot and leg were recorded and entered as 'Day 1' values.   
 
Foot - 12 cm from tip of the great toe. 
Leg – At 10, 20, 30 cms from medial malleolus.   
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Treatment Protocol: 
 
 Patients belonging to both groups were received in a Filarial cot 
with a standard elevation of 6" at the Foot end. 
 
Nodo-Venous Shunt Group: 
 
 Taken up for surgery in 2-3 days. 
 
Procedure:- 
 
Carried out under local anesthesia. 
 
Linear incision in the groin along the line of femoral vein deepened 
upto subcutaneous level. Long saphenous Vein identified along with 
adjacent lymph node.  
 
LSVn cut bearing a proximal stump of adequate length for the 
Nodovenous shunt.  This cut end was anastamosed with the Lymphnode. 
Wound closed in layers. 
 
Received back in the ward in the filarial cot.  Advised to carry on 
active flexion extension exercises of the ankle. 
 
Suture removal between 10-12 days.  
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VOLUMETRIC 
MEASUREMENT CHAMBER 
  
 
 
 
 
 
 
 
 
 
 
 
SEQUENTIAL PUMP WITH VARYIING 
SIZES OF ENCASEMENTS (SLEEVE) 
Pump Therapy: 
 
 Right from Day1, sequential Pneumatic Pump therapy was 
administered for not less than 90 minutes (90-100 mins.) on a daily basis 
through out their stay in the hospital (2 weeks). 
 
Procedure: 
 
 With the patient lying supine, the custom made sleeve 
(encasement) of the Pump was worn around the edematous limb. Once 
the sleeve was in place, the Pump was started which provided a 
sequential compression of various segments of the lower limb.  A 
pressure varying between 50-100 mm of Hg was generated during each 
compression. 
 
 This procedure was repeated daily.  Patient was advised to lie in 
the filarial cot with the foot end elevated and practice active exercises.   
 
 
 Both these groups of patients were discharged at the end of 2 
weeks. 
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Subsequent to discharge from the hospital, patients belonging to 
both groups were advised,  
 
- to wear elastic stockings for compression which extended from 
the distal end of the foot to above-knee level 
 
- to keep limb elevated as much as possible 
 
- to report for Penidure prophyloxis once in 15 days. During 
which they received an I.M injection of  Benzathine Penicillin 
12 lacs units after test dose and Diethyl Carbamazine (DEC) 
tablets for 3 days (150mgm twice daily basis). 
Record of measurements:- 
 
 It was carried out on Days-7, 30 and 180 at the standard sites as on 
Day1. 
 
 The difference was interpreted as reduction or gain in edema and 
was expressed in percentage (by taking the initial recording as 100%). 
 
 
Follow-up: 
 
 Patients were followed-up as they reported for the Penidure 
prophylaxis once in 15 days. 
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PUMP THERAPY IN PROGRESS 
NODOVENOUS SHUNT 
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Pump 
Group 
NV Shunt 
Group 
Sequential  
Pump NV Shunt 
Daily basis 
90-120 mts. 
       12 days 
Suture removal on 12th day 
Discharged 
(2 weeks) 
-  Elastic Compression 
-  Limb elevation 
-  Regular Penidure prophyloxis[[ 
(Periodic evaluation using 
measurements on days 7, 30 
and 180) 
Statistical Analysis :- 
 
 
 It was done using Paired-Samples t test which compares the means 
of two variables that represent the same group at different times.  
 
 The mean values for the two variables are calculated. 
 
 A low significance value for the t test (typically less than 0.05) 
indicates there is significant difference between the two variables.  
 
 
 In the current study, mean difference values were obtained for both 
leg and foot.  In the leg 20 cms level was taken as a representative site.  
 
 
Compliance: 
 
 Compliance was recorded by awarding points.  
 Regular visits for Penidure prophylaxis-1  
 Limb elevation – 2 
 Wearing of Elastic Compression – 3 
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AGE 
0
2
4
6
8
10
12
10 - 20 21 – 30 31 - 40 41 – 50 51 – 60 61 - 70
AGE
FR
E
Q
U
E
N
C
Y
Frequency Pump
Frequency Shunt
RESULTS 
 
AGE: 
 
 
Number of Cases 
Age 
(years) Pump 
(No) 
Shunt 
10 - 20 1 1 
21 – 30 3 6 
31 - 40 11 8 
41 – 50 6 7 
51 – 60 3 3 
61 - 70 1 0 
Total 25 25 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The maximum number  of  patients in both groups were found to 
be  in  the 31-40 age group. 
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SEX 
0
2
4
6
8
10
12
14
16
Pump Shunt
GROUP
FR
EQ
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Y
Male
Female
 
 
ii. SEX 
 
   
Group Male Female Total 
Pump 15 10 25 
Shunt 14 11 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 In both the groups, males were found to be more in number when 
compared to females.  
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SIDE OF THE LEG INVOLVED
0
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Right
Left
 
iii.  SIDE: 
 
 
Group Right Left Total 
Pump 18 7 25 
Shunt 13 12 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Right side was predominant in both groups. 
 
 
45 
GRADING OF LEG 
0
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20
25
Pump Shunt
GROUP
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Grade II
 
iv. GRADE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Pump group had more number of Grade I patients.  
Shunt group had more number of Grade II patients. 
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Group Grade I Grade II Total 
Pump 16 9 25 
Shunt 5 20 25 
 
CLINICAL FEATURES: 
 
 
 
NUMBER OF CASES 
PARAMETER 
PUMP SHUNT 
Fever 25 25 
Adenitis 23 25 
Pain 11 13 
Fungus 0 3 
Caries 1 2 
Hydrocele 0 1 
Family history 1 1 
 
 
 
Fever was present in all the patients studied in both groups.  
 
Adenitis was also present in 23 of 25 patients in the Pump group and all 
the patients included in the Shunt group had Adenitis. 
 
Pain was present in only among 11 patients in the Pump group and 
among 13 patients in the Shunt group. 
 
In the associated illnesses studied-(viz. Fungal infection, Caries and 
Hydrocele) Fungal infection was present only in 3 patients of the Shunt 
group. 
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Caries tooth was found in 1 patient of the Pump group and 2 of the Shunt 
group. 
 
Hydrocele was detected in 1 patient of the Shunt group. 
 
Family history was present in 1 patient from each group.  
 
Patients with associated illnesses were appropriately treated. 
 
Regarding the skin texture an observation was made. 
 
Patients undergoing Nodo-venous Shunt had a supple skin whereas those 
under Pump therapy had a firm texture. 
 
 
MEASUREMENTS: 
 
 
 
 Mean value of Paired-samples statistics at 12cm for the Foot and 
20 cm for the Leg were obtained and analysed.  
 
 The Mean value of Day1 was taken as Baseline value and 
compared with Days-7, 30, 180 using Paired-sample t test. 
 
Results are tabulated as follows:- 
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1. PUMP THERAPY 
 
1-1:   Foot (at 12 cms) 
 
Paired Difference 
Mean 
Difference 
Cms 
Percentage p  value 
Day 1 and Day 7 0.92 3.59 % 0.005  * 
Day 1 and Day 30 1.28 4.99 % 0.005  * 
Day 1 and Day 180 0.88 3.43 % 0.005  * 
 
* - Significant 
 
 
 
REDUCTION AT FOOT LEVEL
0
1
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6
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 R
ED
U
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N
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1-2:   Leg (at 20 cms) 
 
 
Paired Difference 
Mean 
Difference 
Cms 
Percentage p  value 
Day 1 and Day 7 2.16 7 % 0.005  * 
Day 1 and Day 30 2.28 7.4 % 0.005  * 
Day 1 and Day 180 1.4 4.54 % 0.005  * 
 
* - Significant 
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The mean difference values obtained for both Foot and Leg was found to 
be statistically significant as evidenced by the p value (< .005). 
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2.  SHUNT THERAPY 
 
2-1:   Foot (at 12 cms) 
 
 
Paired Difference 
Mean 
Difference 
Cms 
Percentage p  value 
Day 1 and Day 7 2.08 7.84  0.005  * 
Day 1 and Day 30 2.48 9.35  0.005  * 
Day 1 and Day 180 2.44 9.2  0.005  * 
 
*  - Significant 
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REDUCTION AT LEG
0
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2-2:   Leg (at 20 cms) 
 
 
Paired Difference 
Mean 
Difference 
Cms 
Percentage p  value 
Day 1 and Day 7 3.12 9.44  0.005  * 
Day 1 and Day 30 4.28 12.95  0.005  * 
Day 1 and Day 180 4.12 12.46  0.005  * 
 
 
* - Significant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mean difference values obtained for both Foot and Leg was found to 
be statistically significant as evidenced by the p value (< .005) 
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COMPARISON BETWEEN THE 
PUMP THERAPY AND SHUNT THERAPY 
 
 
Difference in reduction at Foot:   
 
Table 1 
 
PUMP SHUNT 
Paired Difference Mean Difference 
Cms 
Percentage 
Mean 
Difference 
Cms 
Percentage 
Day 1 and Day 7 0.92 3.59  2.08 7.84  
Day 1 and Day 30 1.28 4.99  2.48 9.35  
Day 1 and Day 180 0.88 3.43  2.44 9.2  
 
 
 
 
Difference in Reduction at Leg: 
 
 
Table 2 
 
PUMP SHUNT 
Paired Difference Mean Difference
Cms 
Percentage 
Mean 
Difference 
Cms 
Percentage 
Day 1 and Day 7 2.16 7  3.12 9.44  
Day 1 and Day 30 2.28 7.4  4.28 12.95  
Day 1 and Day 180 1.4 4.54  4.12 12.46  
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• Both groups exhibit a statistically significant reduction. 
 
• Day 30 shows the best reduction in both groups and in both 
modalities of treatment. 
 
• As it approaches Day 180 some amount of reduction is lost but still 
the reduction is maintained in both groups. 
 
• On comparison, the Shunt group of patients exhibit more reduction 
than of the Pump group of patients. 
 
COMPLIANCE: 
 
FREQUENCY 
SCORES 
PUMP SHUNT 
1 – 4 18 18 
4 – 6 7 7 
 
 
 
Only 7 patients out of 25 in each group could score 4 and above which 
suggests that these were the patients who followed the advise of Limb 
elevation, wearing of Compression stockings and making regular 
periodical visits for Penidure prophylaxis. 
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DISCUSSION 
 
 
 
 On analysing the data in my study- Comparison of Pump therapy 
and Nodo-venous Shunt therapy on early Filarial Lymphedema (i.e. 
Grade I and II  legs, the results of the study has shown, 
 
 
That Pump therapy produces statistically significant reduction at 
both Feet and Legs.  
 
 
The analysis of the Shunt group also show a statistically significant 
reduction in both feet and legs which was higher than that of the 
Pump group. 
 
 
On studying the trends of reduction, it was noticed that patients 
showed maximum reduction on Day 30 in both groups.  
 
 
Day 180 evaluation revealed that both groups tend to have a 
marginal increase in circumference at both foot and leg levels, but 
still, the reduction that was present was statistically significant 
when compared to the circumference on Day 1. 
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This may be due to the changes that occur in the legs which tend to 
become more fibrotic as time goes on. Other factors or limitations 
that might contribute are, the failure on the patients' part to apply 
elastic compression as they were taught and failure to adhere to 
antibiotic prophylaxis.  
  
Having found that, Pump therapy is also an effective tool in the 
management of early Filarial Lymphedema and being a non-
invasive procedure, it can be used in selected patients.  Also the 
results of Pump therapy are in line with that of Nodo-venous Shunt 
therapy which has been a bench mark in the management of 
Lymphedema in our institution, thereby increasing our options in 
the treatment of Filarial Lymphedema – at least in early cases 
(Grade I & II). 
  
As often quoted in studies sustained compression by diligent 
wearing of elastic devices – garments, stockings, bandages is of 
importance which needs patients' education followed by patient co-
operation.  (39) 
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CONCLUSION 
 
 
 
 Pump therapy and Nodo-venous Shunt therapy are effective as 
separate treatment modalities in the treatment of Early Filarial 
Lymphedema (Grade I & II Legs). 
 
 Patients on Nodo-venous Shunt therapy show increase amount of 
reduction when compared with that of the Pump therapy patients. 
 
 Pump therapy being a non-invasive procedure is an useful tool in 
the treatment of early Filarial Lymphedema and also in patients unwilling 
to undergo any form of surgery. 
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APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROFORMA 
 
 
NAME  : 
AGE   : 
SEX   : 
IP/OP NUMBER :     
OCCUPATION :   ADDRESS: 
 
 
LEG INVOLVED : R  L BIL 
 
HISTORY:- 
 
 Duration: 
 Fever   Rigors: 
 Adenitis : 
 Pain  : 
       Associated illness: 
 Fungus : 
 Caries tooth : 
 Hydrocele : 
 
FAMILY HISTORY : 
 
TREATMENT HISTORY: 
 
 
 Penidure prophylaxis 
 
    
Yes      No 
 
    Duration:  
 
 
EVALUATION : 
  
GRADING OF LEG :     I    /     II 
ALLOTMENT:  Pump Therapy /  NV Shunt 
 
MEASUREMENTS: 
 
 
Post-Op / Post-Pump 
Level Primary 
1 Week 1 month 6 months 
Foot – 12 Cms     
Leg  -  10 Cms     
            20 Cms     
            30 Cms     
Difference + / -     
 
 
COMPLICATIONS: 
 
 Wound infection: 
 Lymphorrhea: 
 Systemic illness: 
 
COMPLIANCE: 
 
 Limb elevation 
 Compression 
 Follow-up 
 
 
 
 
PUMP THERAPY – MASTER CHART 
History Associated illness MEASUREMENTS 
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1 47 M R 12 YES YES YES NO NO NO NO 4 2 26 25 25 25 28 26 26 29 31 30 30 33 34 32 32 35 NO 1 
2 42 F R 18 YES YES NO NO NO NO NO 12 2 26 24 24 24 28 26 25 26 31 29 29 29 33 30 29 30 NO 6 
3 38 F R 7 YES YES NO NO NO NO NO 2 1 27 25 25 25 29 28 29 30 33 32 33 35 35 33 34 37 NO 1 
4 18 F R 9 YES YES NO NO NO NO NO 3 1 21 20 20 20 25 23 23 24 27 23 22 23 29 26 25 25 NO 6 
5 43 M L 18 YES YES NO NO NO NO NO 12 1 27 26 26 27 30 29 28 32 32 30 31 35 35 33 34 37 NO 1 
6 34 F L 8 YES YES YES NO NO NO NO 6 1 24 23 23 23 27 25 25 24 29 27 27 27 30 28 29 29 NO 6 
7 41 F R 18 YES YES NO NO NO NO NO 12 1 25 24 24 24 28 26 26 27 31 28 27 27 33 30 29 28 NO 3 
8 48 M R 24 YES YES YES NO NO NO NO 6 2 29 28 28 30 29 27 26 27 32 29 29 30 38 37 38 40 NO 3 
9 34 M R 36 YES YES NO NO NO NO NO 5 2 30 28 28 29 31 30 30 32 34 32 32 33 38 36 37 38 NO 1 
10 38 F R 9 YES YES YES NO NO NO NO 2 1 23 23 23 23 26 25 25 24 29 27 26 27 31 30 29 29 NO 3 
11 37 F L 12 YES YES NO NO NO NO NO 3 1 26 27 26 26 29 27 27 28 30 28 28 28 32 31 30 30 NO 6 
12 40 M L 8 YES YES YES NO NO NO NO 4 1 28 27 27 28 30 28 29 29 33 31 32 31 36 34 34 33 NO 3 
13 38 M R 24 YES YES NO NO NO NO NO 12 2 26 25 24 23 28 26 25 25 30 27 26 27 32 29 29 30 NO 6 
14 34 F R 24 YES YES YES NO NO NO NO 7 2 25 24 23 25 29 28 28 30 32 31 31 33 34 33 33 34 NO 3 
15 34 M R 9 YES YES NO NO NO NO NO 2 2 26 25 24 24 29 28 27 27 34 32 31 30 36 35 34 34 NO 6 
16 32 F R 24 YES YES NO NO NO NO NO 6 2 23 23 23 24 29 26 27 28 31 28 29 32 34 32 33 36 NO 1 
17 52 M L 60 YES YES NO NO NO NO NO 36 2 26 25 24 24 28 26 24 26 30 27 28 29 33 30 30 32 NO 3 
18 53 F R 5 YES YES YES NO NO NO NO 1 1 24 23 23 24 25 23 22 23 28 28 28 28 32 32 30 30 NO 1 
19 28 M R 24 YES YES YES NO YES NO YES 0 1 24 23 22 23 24 22 21 21 29 26 25 25 34 31 31 32 NO 3 
20 25 M R 9 YES NO NO NO NO NO NO 2 1 28 26 26 25 30 29 30 30 34 32 32 33 37 35 35 36 NO 1 
21 47 M L 24 YES YES YES NO NO NO NO 4 1 25 24 23 23 26 24 23 24 29 27 26 26 33 32 31 31 NO 1 
22 61 F R 6 YES YES NO NO NO NO NO 2 1 24 24 24 25 29 27 27 27 30 27 28 28 32 31 31 31 NO 3 
23 53 M R 8 YES NO NO NO   NO NO 3 1 25 24 24 24 28 27 27 28 30 28 27 29 32 30 30 31 NO 1 
24 26 M R 9 YES YES YES NO NO NO NO 2 1 27 26 25 25 27 25 25 24 30 28 27 27 32 31 30 30 NO 6 
25 40 F L 18 YES YES NO NO NO NO NO 8 1 26 26 25 26 29 28 27 27 31 29 29 30 33 31 30 30 NO 1 
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1 51 f lt 12 yes yes no no no no nil 12 1 25 23 21 21 29 26 23 23 34 31 29 30 36 33 31 31 no 5 
2 29 f lt 12 yes yes no no no no nil 0 1 25 26 25 25 28 25 24 24 32 30 29 29 37 34 34 34 no 3 
3 39 m lt 36 yes yes yes no no no nil 18 2 29 26 25 25 33 30 29 30 36 32 31 31 39 35 34 34 no 6 
4 39 f rt 24 yes yes no no no no nil 7 2 28 26 26 28 30 28 28 29 31 29 28 30 34 33 33 35 no 1 
5 32 f lt 18 yes yes yes yes no no yes 6 2 26 24 24 24 31 30 30 30 34 32 31 32 36 35 34 33 no 6 
6 28 m rt 30 yes yes no no no no nil 1 2 29 26 26 26 32 29 28 28 34 31 29 29 36 32 31 31 no 3 
7 42 m rt 8 yes yes no no no no nil 2 2 29 27 27 26 31 28 28 26 33 30 30 29 34 31 31 30 no 1 
8 21 f rt 9 yes yes no no no no nil 3 2 28 25 24 24 30 27 26 25 32 29 28 27 33 29 29 29 no 6 
9 48 m lt 24 yes yes yes no no no nil 12 2 26 25 24 24 29 26 26 25 31 28 27 26 33 30 29 29 no 3 
10 38 f rt 36 yes yes no no no no nil 24 2 28 25 24 24 34 32 30 30 37 34 33 34 39 36 35 35 no 3 
11 22 f lt 36 yes yes no no yes no nil 24 2 26 23 23 23 23 29 26 25 31 29 27 26 32 30 29 29 no 3 
12 52 m rt 48 yes yes no no no yes nil 12 2 27 25 25 25 32 29 29 28 35 32 30 30 36 33 32 31 no 6 
13 41 m rt 48 yes yes yes no no no nil 30 2 24 22 22 22 28 26 24 24 30 26 25 25 32 28 28 28 no 3 
14 40 f lt 36 yes yes yes no no no nil 18 2 27 25 25 24 28 25 24 24 31 29 28 29 32 29 28 30 no 3 
15 38 m rt 36 yes yes no no no no nil 24 2 27 25 24 24 25 33 32 31 38 35 33 35 40 36 34 35 no 1 
16 41 m lt 30 yes yes yes no no no nil 24 2 27 24 23 24 31 28 27 27 34 30 29 29 37 32 32 33 no 1 
17 48 m rt 36 yes yes yes no no no nil 12 2 28 25 25 24 30 27 26 25 34 30 29 29 37 35 34 34 no 6 
18 43 f rt 18 yes yes yes yes no no nil 6 2 23 22 22 22 29 26 25 25 33 29 28 27 36 32 32 32 no 3 
19 45 f lt 36 yes yes yes no no no nil 24 2 25 23 22 22 30 27 25 26 31 27 26 26 35 30 30 30 no 6 
20 24 m rt 12 yes yes yes no no no nil 1 1 26 25 25 25 31 28 28 27 34 30 30 29 36 32 31 30 no 1 
21 34 f lt 24 yes yes no no yes no nil 8 1 24 22 22 22 27 24 23 24 29 26 25 25 31 29 28 28 no 3 
22 56 f rt 36 yes yes yes yes no no nil 12 2 30 27 27 28 34 31 30 31 38 34 32 33 41 38 37 37 no 1 
SHUNT THERAPY – MASTER CHART 
23 17 f lt 18 yes yes yes no no no nil 3 2 28 25 25 26 30 27 26 28 33 30 29 30 39 36 35 37 no 1 
24 40 m lt 42 yes yes yes no no no nil 8 2 22 21 21 21 24 22 21 21 29 26 25 25 31 29 27 27 no 3 
25 23 m rt 9 yes yes no no no no nil 2 1 26 24 24 23 27 24 23 24 32 29 28 28 33 31 32 32 no 1 
 
